Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: Standards of practice for RA treatment

F. Wolfe, Q. Rehman, Nancy E Lane, J. Kremer

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: Standards of practice for RA treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences